News
A new cancer vaccine targeting KRAS gene mutations shows promise in preventing pancreatic and colorectal cancer recurrence in ...
A new study reveals promising results for a vaccine targeting colorectal and pancreatic cancers. Researchers from the ...
An 'off-the-shelf' vaccine may help prevent or delay cancer recurrence in people with hard-to-treat colorectal or pancreatic ...
23h
TipRanks on MSNAstraZeneca’s Selumetinib Study Update: Potential Game-Changer for KRAS-Positive NSCLC
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
New clinical data reveals promising efficacy of VS-7375, a KRAS G12D inhibitor, in advanced lung cancer, highlighting its ...
Operator: Good morning, everyone, and welcome to the Edible Garden Incorporated 2025 Second Quarter Business Update ...
AbbVie unveiled a $195 million investment to expand active pharmaceutical ingredient manufacturing in the U.S. Bloomberg reported that BlinkRx, a company that has Donald Trump Jr. on its board, just ...
Dementia-like protein clumps found in pancreatic precancer mouse cells point to autophagy defects, offering cancer ...
Discover key insights from Edible Garden AG's Q2 2025 earnings call: strategic shifts, private label growth, new product launches, and bullish ...
Cancer Research UK-funded researchers find dementia-like behaviour in pancreas cells at risk of turning into cancer. The researchers noticed excess “problem protein” molecules forming clumps in these ...
Dr. Zev Wainberg of UCLA recently spoke with CURE about trial results concerning the cancer vaccine ELI-002 2P.
Revolution Medicines Inc. (NASDAQ: RVMD) is one of the best upside stocks to invest in now. Earlier on July 23, Revolution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results